The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Prognostic impact of tumor MET expression among patients with stage IV gastric cancer: A Danish cohort study.
Rune Erichsen
Research Funding - Amgen
Kelly S. Oliner
Employment or Leadership Position - Amgen (B)
Michael A. Kelsh
Employment or Leadership Position - Amgen
Stock Ownership - Amgen
Karsten B. Nielsen
Employment or Leadership Position - DAKO (U)
Trine Frøslev
Research Funding - Amgen
Anne-Vibeke Lænkholm
Consultant or Advisory Role - DAKO
Honoraria - DAKO
Mogens Vyberg
No relevant relationships to disclose
John F. Acquavella
Employment or Leadership Position - Amgen
Stock Ownership - Amgen
Henrik Toft Sørensen
Research Funding - Amgen